Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2018 1
2019 4
2020 2
2021 2
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Post-traumatic Stress Disorder.
Merians AN, Spiller T, Harpaz-Rotem I, Krystal JH, Pietrzak RH. Merians AN, et al. Med Clin North Am. 2023 Jan;107(1):85-99. doi: 10.1016/j.mcna.2022.04.003. Epub 2022 Oct 28. Med Clin North Am. 2023. PMID: 36402502 Review.
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Neuropsychopharmacology. 2022 Jul;47(8):1574-1581. doi: 10.1038/s41386-022-01266-9. Epub 2022 Jan 19. Neuropsychopharmacology. 2022. PMID: 35046508 Free PMC article. Clinical Trial.
Is the European Patent Office's approach to assessing obviousness of antibody inventions consistent?
Rigby B. Rigby B. Expert Opin Ther Pat. 2014 Dec;24(12):1283-5. doi: 10.1517/13543776.2014.981255. Expert Opin Ther Pat. 2014. PMID: 25407281
This article looks at the rationale behind the European Patent Office's (EPO) current approach to assessing the patentability of antibodies, contrasting it with US practice as well as the EPO's assessment of obviousness in the chemical field. ...
This article looks at the rationale behind the European Patent Office's (EPO) current approach to assessing the patentability of anti …
Sex-Specific Genetic and Transcriptomic Liability to Neuroticism.
Wendt FR, Pathak GA, Singh K, Stein MB, Koenen KC, Krystal JH, Gelernter J, Davis LK, Polimanti R. Wendt FR, et al. Biol Psychiatry. 2023 Feb 1;93(3):243-252. doi: 10.1016/j.biopsych.2022.07.019. Epub 2022 Aug 5. Biol Psychiatry. 2023. PMID: 36244801 Free PMC article.
The Journal of Molecular Diagnostics: 20 Years of Clinical Innovation.
O'Leary TJ. O'Leary TJ. J Mol Diagn. 2019 Nov;21(6):935-937. doi: 10.1016/j.jmoldx.2019.09.002. J Mol Diagn. 2019. PMID: 31635796 Free article.
This guest editorial highlights 20 years of clinical innovation in JMD....
This guest editorial highlights 20 years of clinical innovation in JMD....
18 results